{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:06Z","timestamp":1791561246022,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425050"],"award-info":[{"award-number":["82425050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M730125"],"award-info":[{"award-number":["2023M730125"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.coi.2025.102563","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:31:42Z","timestamp":1746876702000},"page":"102563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms"],"prefix":"10.1016","volume":"94","author":[{"given":"Mingjia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-2861","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102563_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2025.102563_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jamadermatol.2024.2517","article-title":"Long-term effectiveness and reasons for discontinuation of dupilumab in patients with atopic dermatitis","volume":"160","author":"Boesjes","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.16447","article-title":"It's a traumatic illness, traumatic to witness': a qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma","volume":"179","author":"Orlowska","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102563_sbref5","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/jdv.19325","article-title":"Histology-based classifier to distinguish early mycosis fungoides from atopic dermatitis","volume":"37","author":"Roenneberg","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2025.102563_bib6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jaci.2022.02.015","article-title":"T cells in the skin: lymphoma and inflammatory skin disease","volume":"149","author":"Roediger","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2025.102563_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaad.2024.03.039","article-title":"Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study","volume":"91","author":"Hasan","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdcr.2020.12.010","article-title":"Acceleration of cutaneous T-cell lymphoma following dupilumab administration","volume":"8","author":"Russomanno","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.coi.2025.102563_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdcr.2023.01.008","article-title":"Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab","volume":"33","author":"Choo","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.coi.2025.102563_bib10","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0959-8049(19)30628-8","article-title":"A case of mycosis fungoides with large cell transformation following dupilumab treatment","volume":"119","author":"Poyner","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.coi.2025.102563_bib11","article-title":"Cutaneous T-cell lymphoma progression: a potential dupilumab pitfall","volume":"15","author":"Malick","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.coi.2025.102563_bib12","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.2234","article-title":"Development of nodular lesions after dupilumab therapy in erythrodermic mycosis fungoides with interleukin-13 receptor alpha2 expression","volume":"102","author":"Hashimoto","year":"2022","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.coi.2025.102563_bib13","doi-asserted-by":"crossref","DOI":"10.5070\/D3264048364","article-title":"Development of S\u00e9zary syndrome following the administration of dupilumab","volume":"26","author":"Tran","year":"2020","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.coi.2025.102563_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2340\/00015555-3208","article-title":"Diagnosis of mycosis fungoides following administration of dupilumab for misdiagnosed atopic dermatitis","volume":"99","author":"Chiba","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coi.2025.102563_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12185-022-03330-y","article-title":"Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis","volume":"116","author":"Nakazaki","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.coi.2025.102563_bib16","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1111\/1346-8138.15501","article-title":"Dupilumab therapy in Sezary syndrome misdiagnosed as atopic dermatitis: a case report","volume":"47","author":"Umemoto","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib17","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3576","article-title":"Dupilumab treatment in two patients with cutaneous T-cell lymphomas","volume":"100","author":"Lazaridou","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coi.2025.102563_bib18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/ced.15079","article-title":"Dupilumab unmasking cutaneous T-cell lymphoma: report of a fatal case","volume":"47","author":"Poyner","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/dermatopathology9040045","article-title":"Dupilumab-associated mycosis fungoides with a CD8+ immunophenotype","volume":"9","author":"Park","year":"2022","journal-title":"Dermatopathology"},{"key":"10.1016\/j.coi.2025.102563_bib20","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00403-023-02652-z","article-title":"Dupilumab-associated mycosis fungoides: a cross-sectional study","volume":"315","author":"Hamp","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.coi.2025.102563_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/DAD.0000000000001875","article-title":"Evolution of dupilumab-associated cutaneous atypical lymphoid infiltrates","volume":"43","author":"Sokumbi","year":"2021","journal-title":"Am J Derm"},{"key":"10.1016\/j.coi.2025.102563_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jdcr.2021.09.020","article-title":"Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab","volume":"18","author":"Du-Thanh","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.coi.2025.102563_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdcr.2022.12.013","article-title":"Lichenoid-granulomatous drug reactions to dupilumab: a report of 2 cases","volume":"33","author":"Rehan","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.coi.2025.102563_bib24","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.12788\/cutis.0074","article-title":"Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma","volume":"106","author":"Hollins","year":"2020","journal-title":"Cutis"},{"key":"10.1016\/j.coi.2025.102563_bib25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ced\/llad277","article-title":"Mycosis fungoides and Sezary syndrome following dupilumab treatment: experience of two Italian tertiary care centres","volume":"48","author":"Buffon","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib26","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/DER.0000000000000679","article-title":"Mycosis fungoides unmasked by dupilumab treatment in a patient with a history of atopic dermatitis","volume":"32","author":"Ayasse","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.coi.2025.102563_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15290","article-title":"Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: a case report","volume":"35","author":"Amagai","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.coi.2025.102563_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients","volume":"83","author":"Espinosa","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13880","article-title":"Progression of mycosis fungoides after treatment with dupilumab: a case report","volume":"33","author":"Miyashiro","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.coi.2025.102563_bib30","first-page":"1","article-title":"Rapid progression of cutaneous T-cell lymphoma in a patient with erythroderma during dupilumab treatment, following prior sequential azathioprine, baricitinib and cyclosporine treatments","volume":"90","author":"Hsieh","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.coi.2025.102563_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jdcr.2022.04.023","article-title":"A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab","volume":"24","author":"Ahatov","year":"2022","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.coi.2025.102563_bib32","doi-asserted-by":"crossref","DOI":"10.5070\/D3271052041","article-title":"Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab","volume":"27","author":"Newsom","year":"2021","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.coi.2025.102563_sbref33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamadermatol.2023.3849","article-title":"Dupilumab-associated lymphoid reactions in patients with atopic dermatitis","volume":"159","author":"Boesjes","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.coi.2025.102563_bib34","first-page":"e114","article-title":"Cutaneous T-cell lymphoma and dupilumab use: a retrospective matched cohort study of clinical characteristics and treatment outcomes","volume":"39","author":"Stuver","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2025.102563_sbref35","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/jdv.20053","article-title":"Detecting T-cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab","volume":"38","author":"Kook","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.coi.2025.102563_bib36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaad.2024.10.119","article-title":"Cutaneous T cell lymphoma arising in patients treated with dupilumab: a case series of 18 patients","volume":"92","author":"Accetta","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cup.12470","article-title":"Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas","volume":"42","author":"Vandergriff","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.coi.2025.102563_bib38","first-page":"83","article-title":"Diagnosis of T-cell lymphoid proliferations of the skin: putting all the pieces together","volume":"33","author":"Torres-Cabala","year":"2020","journal-title":"Mod Pathol J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.coi.2025.102563_bib39","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.jaad.2013.07.049","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.coi.2025.102563_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jid.2024.08.015","article-title":"Cutaneous T-cell lymphoma and dupilumab use: a multifactorial and complex story","volume":"145","author":"Beylot-Barry","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.coi.2025.102563_sbref41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jid.2024.06.1272","article-title":"Cutaneous T-cell lymphoma after dupilumab use: a real-world pharmacovigilance study of the FDA adverse event reporting system","volume":"145","author":"Lavin","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102563_bib42","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102563_bib43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/jdv.17001","article-title":"Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sezary syndrome","volume":"35","author":"Steck","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.coi.2025.102563_sbref44","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2024.10.028","article-title":"Integrative epidemiology and immuno-transcriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy","volume":"155","author":"Cabrera-Perez","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2025.102563_bib45","doi-asserted-by":"crossref","first-page":"25114","DOI":"10.1074\/jbc.M100936200","article-title":"Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain","volume":"276","author":"Kawakami","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2025.102563_bib46","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1172\/JCI24274","article-title":"Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion","volume":"116","author":"Fischer","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102563_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/asj\/sjac234","article-title":"CD30 regulation of IL-13-STAT6 pathway in breast implant-associated anaplastic large cell lymphoma","volume":"43","author":"Kadin","year":"2023","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.coi.2025.102563_bib48","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jid.2023.10.018","article-title":"Deciphering tumor cell evolution in cutaneous T-cell lymphomas: distinct differentiation trajectories in mycosis fungoides and Sezary syndrome","volume":"144","author":"Jiang","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"55","key":"10.1016\/j.coi.2025.102563_bib49","doi-asserted-by":"crossref","first-page":"eabe2749","DOI":"10.1126\/sciimmunol.abe2749","article-title":"Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Ralpha blockade","volume":"6","author":"Bangert","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2025.102563_sbref50","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41586-024-07762-w","article-title":"Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission","volume":"634","author":"Bai","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102563_sbref51","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-024-07962-4","article-title":"The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8(+) T cells against cancer","volume":"634","author":"Feng","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102563_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","article-title":"An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis","volume":"625","author":"LaMarche","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102563_bib53","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","article-title":"Ovarian cancer-derived IL-4 promotes immunotherapy resistance","volume":"187","author":"Mollaoglu","year":"2024","journal-title":"Cell"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:28:27Z","timestamp":1777782507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"alternative-id":["S0952791525000391"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102563","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102563"}}